Stone clearance times with mini-percutaneous nephrolithotomy: Comparison of a 1.5 mm ballistic/ultrasonic mini-probe vs. laser.


Journal

Canadian Urological Association journal = Journal de l'Association des urologues du Canada
ISSN: 1911-6470
Titre abrégé: Can Urol Assoc J
Pays: Canada
ID NLM: 101312644

Informations de publication

Date de publication:
Jan 2021
Historique:
pubmed: 24 7 2020
medline: 24 7 2020
entrez: 24 7 2020
Statut: ppublish

Résumé

A limitation of mini-percutaneous nephrolithotomy (mPCNL) is the narrow working channel of mini-nephroscopes, typically restricting instrumentation to 5 French (F) or smaller. We evaluated the efficacy of the 1.5 mm Swiss LithoClast A retrospective review of 30 consecutive mPCNL cases using the Trilogy and 30 W Holmium laser was performed. A 12 F MIPS nephroscope with a 16.5 F access sheath and 6.7 F working channel was used for all mPCNL cases. The Trilogy was used with a disposable 1.5 mm × 440 mm probe with dual ultrasonic and ballistic energy. The Ho:YAG laser was used with a 550 micron fibre and a maximum of 30 W. Stone clearance time (SCT) was defined by the total time interval between activation of the lithotripter until insertion of the nephrostomy tube and measured in mm Eleven cases using a 1.5 mm Trilogy probe and 16 cases using a Ho:YAG laser met final inclusion criteria. Three cases using the Trilogy were excluded from final analysis due to conversion to alternative energy sources - two of those were upsized to standard PCNL and one was converted to laser. Mean stone diameter and density in the final Trilogy cohort was 26.7 mm and 1193 Hounsfield units (HU). Mean diameter and density in the laser cohort was 25.2 mm and 1049 HU. The mean stone area clearance time for Trilogy was 4.7±1.8 mm The 1.5 mm mPCNL Trilogy probe was comparable to 30 W Ho:YAG laser for clearing hard stones. The Trilogy performed better than laser on soft stones with a HU density <1000 HU.

Identifiants

pubmed: 32701444
pii: cuaj.6513
doi: 10.5489/cuaj.6513
pmc: PMC7769519
doi:

Types de publication

Journal Article

Langues

eng

Pagination

E17-E21

Références

J Endourol. 2015 Nov;29(11):1248-52
pubmed: 25177768
J Endourol. 2017 Nov;31(11):1101-1110
pubmed: 28950716
World J Urol. 2013 Dec;31(6):1605-10
pubmed: 23334470
BJU Int. 2017 May;119 Suppl 5:39-46
pubmed: 28544299
BJU Int. 2018 Dec;122(6):1034-1040
pubmed: 29873874
J Endourol. 2013 Dec;27(12):1444-9
pubmed: 24251428
Int J Urol. 2005 Jun;12(6):544-7
pubmed: 15985075
World J Urol. 2020 Apr;38(4):1043-1050
pubmed: 31177306
BJU Int. 2011 Mar;107(5):824-828
pubmed: 21355982
J Endourol. 2014 Feb;28(2):256-60
pubmed: 24074324
J Endourol. 2018 Jun;32(6):534-540
pubmed: 29649900
J Endourol. 2020 Feb;34(2):151-155
pubmed: 31588790
J Endourol. 2000 Jun;14(5):419-21
pubmed: 10958563
J Endourol. 2017 Nov;31(11):1145-1151
pubmed: 28859485
BJU Int. 2011 Sep;108(6):896-9; discussion 899-900
pubmed: 21477212
World J Urol. 2018 Nov;36(11):1783-1793
pubmed: 29730839
J Endourol. 1995 Oct;9(5):383-6
pubmed: 8580937
Eur Urol. 2017 Aug;72(2):220-235
pubmed: 28237786
World J Urol. 2018 Jul;36(7):1127-1138
pubmed: 29450733
World J Urol. 2015 Apr;33(4):463-9
pubmed: 25185524

Auteurs

Brennan Timm (B)

Department of Urology, Austin Health, University of Melbourne, Melbourne, Australia.

Matthew Farag (M)

Department of Urology, Austin Health, University of Melbourne, Melbourne, Australia.

Niall F Davis (NF)

Department of Urology, Beaumont and Connolly Hospitals, Dublin, Ireland.

David Webb (D)

Department of Urology, Austin Health, University of Melbourne, Melbourne, Australia.

David Angus (D)

Department of Urology, Austin Health, University of Melbourne, Melbourne, Australia.

Andrew Troy (A)

Department of Urology, Austin Health, University of Melbourne, Melbourne, Australia.

Damien Bolton (D)

Department of Urology, Austin Health, University of Melbourne, Melbourne, Australia.

Gregory S Jack (GS)

Department of Urology, Austin Health, University of Melbourne, Melbourne, Australia.

Classifications MeSH